Press Resease

DNA and Gene Chips Market by Type (Oligonucleotide DNA and Complementary DNA), by Product (Consumables and Instruments), by Application (Cancer Diagnosis & Treatment, Gene Expression, Proteomics, Genomics, Drug Discovery, Agricultural Biotechnology, and Others), and by End-User (Academic & Government Research Institutes, Hospitals and Diagnostics Centers, Biotechnology and Pharmaceutical Companies, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 10-Apr-2019 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-4012 Status : Published

Global DNA and gene chips market expected to generate around USD 6.12 billion by 2025, at a CAGR of around 12.5% between 2019 and 2025. DNA and gene chips are also known as DNA microarrays. DNA microarrays are biochips that are used to detect a large number of genes, which are present in a gene sample.

Description

The report covers a forecast and an analysis of the DNA and gene chips market on a global and regional level. The study provides historical data for 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the DNA and gene chips market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the DNA and gene chips market on a global level.

In order to give the users of this report a comprehensive view of the DNA and gene chips market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global DNA and Gene Chips Market

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new assay kits launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market.

The study provides a decisive view of the DNA and gene chips market on the basis of type, product, application, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further bifurcation into major countries including the U.S., UK, Germany, France, China, Japan, India, Brazil, etc.

Some key players of the global DNA and gene chips market are Perkin Elmer, Inc., Illumina, Inc., Thermo Fisher Scientific, Inc., Macrogen Inc., Agilent Technologies, Greiner Bio-One International GmbH, Asper Biotech, CapitalBio Corporation, Microarrays Inc., Oxford Gene Technology, Arrayit Corporation, and bioMérieux SA.

This report segments the global DNA and gene chips market as follows:

Global DNA and Gene Chips Market: Type Analysis

  • Oligonucleotide DNA (o-DNA)
  • Complementary DNA (c-DNA)

Global DNA and Gene Chips Market: Product Analysis

  • Consumables
  • Instruments

Global DNA and Gene Chips Market: Application Analysis

  • Cancer Diagnosis and Treatment
  • Gene Expression
  • Proteomics
  • Genomics
  • Drug Discovery
  • Agricultural Biotechnology
  • Others

Global DNA and Gene Chips Market: End-User Analysis

  • Academic and Government Research Institutes
  • Hospitals and Diagnostics Centers
  • Biotechnology and Pharmaceutical Companies
  • Others

Global DNA and Gene Chips Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global DNA and gene chips market, 2016-2025 (USD Billion)
    • 2.2. Global DNA and gene chips market: Snapshot
  •  
  • Chapter 3. DNA and Gene Chips Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global DNA and gene chips market drivers: Impact analysis
      • 3.2.2. Increase in government funding
      • 3.2.3. The rise in the need for early cancer detection & cancer diagnosis
      • 3.2.4. Growing demand for personalized medicines
    • 3.3. Market Restraints
      • 3.3.1. Global DNA and gene chips market restraints: Impact analysis
      • 3.3.2. High Capital Investments
      • 3.3.3. Alternative Technologies
    • 3.4. Opportunities
      • 3.4.1. Developing countries in the Asia Pacific
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by type
      • 3.6.2. Market attractiveness analysis, by product
      • 3.6.3. Market attractiveness analysis, by application
      • 3.6.4. Market attractiveness analysis, by end-user
      • 3.6.5. Market attractiveness analysis, by region
  •  
  • Chapter 4. Global DNA and Gene Chips Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global DNA and gene chips market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New instruments launch
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  •  
  • Chapter 5. Global DNA and Gene Chips Market - Type Analysis
    • 5.1. Global DNA and gene chips market: Type overview
      • 5.1.1. Global DNA and gene chips market revenue share, by type, 2018 and 2025
    • 5.2. O-DNA (oligonucleotide DNA)
      • 5.2.1. Global DNA and gene chips market for o-DNA, 2016-2025 (USD Billion)
    • 5.3. C-DNA (complementary DNA)
      • 5.3.1. Global DNA and gene chips market for c-DNA, 2016-2025 (USD Billion)
  •  
  • Chapter 6. Global DNA and Gene Chips Market - Product Analysis
    • 6.1. Global DNA and gene chips market: Product overview
      • 6.1.1. Global DNA and gene chips market revenue share, by product, 2018 and 2025
    • 6.2. Consumables
      • 6.2.1. Global DNA and gene chips market for consumables, 2016-2025 (USD Billion)
    • 6.3. Instruments
      • 6.3.1. Global DNA and gene chips market for instruments, 2016-2025 (USD Billion)
  •  
  • Chapter 7. Global DNA and Gene Chips Market - Application Analysis
    • 7.1. Global DNA and gene chips market: Application overview
      • 7.1.1. Global DNA and gene chips market revenue share, by application, 2018 and 2025
    • 7.2. Cancer Diagnosis & Treatment
      • 7.2.1. Global DNA and gene chips market for cancer diagnosis &treatment, 2016-2025 (USD Billion)
    • 7.3. Gene Expression
      • 7.3.1. Global DNA and gene chips market for gene expression, 2016-2025 (USD Billion)
    • 7.4. Proteomics
      • 7.4.1. Global DNA and gene chips market for proteomics, 2016-2025 (USD Billion)
    • 7.5. Genomics
      • 7.5.1. Global DNA and gene chips market for genomics, 2016-2025 (USD Billion)
    • 7.6. Drug Discovery
      • 7.6.1. Global DNA and gene chips market for drug discovery, 2016-2025 (USD Billion)
    • 7.7. Agricultural Biotechnology
      • 7.7.1. Global DNA and gene chips market for agricultural biotechnology, 2016-2025 (USD Billion)
    • 7.8. Others
      • 7.8.1. Global DNA and gene chips market for others, 2016-2025 (USD Billion)
  •  
  • Chapter 8. Global DNA and Gene Chips Market - End-User Analysis
    • 8.1. Global DNA and gene chips market: End-User overview
      • 8.1.1. Global DNA and gene chips market revenue share, by end-user, 2018 and 2025
    • 8.2. Academic & Government Research Institutes
      • 8.2.1. Global DNA and gene chips market for academic & government research institutes, 2016-2025 (USD Billion)
    • 8.3. Hospitals and Diagnostics Centers
      • 8.3.1. Global DNA and gene chips market for hospitals and diagnostics centers, 2016-2025 (USD Billion)
    • 8.4. Biotechnology and Pharmaceutical Companies
      • 8.4.1. Global DNA and gene chips market for biotechnology and pharmaceutical companies, 2016-2025 (USD Billion)
    • 8.5. Others
      • 8.5.1. Global DNA and gene chips market for others, 2016-2025 (USD Billion)
  •  
  • Chapter 9. Global DNA and Gene Chips Market - Regional Analysis
    • 9.1. Global DNA and gene chips market: Regional overview
      • 9.1.1. Global DNA and gene chips market revenue share, by region, 2018 and 2025
    • 9.2. North America
      • 9.2.1. North America DNA and gene chips market, 2016-2025 (USD Billion)
      • 9.2.2. North America DNA and gene chips market revenue, by type, 2016-2025 (USD Billion)
      • 9.2.3. North America DNA and gene chips market revenue, by product, 2016-2025 (USD Billion)
      • 9.2.4. North America DNA and gene chips market revenue, by application, 2016-2025 (USD Billion)
      • 9.2.5. North America DNA and gene chips market revenue, by end-user, 2016-2025 (USD Billion)
      • 9.2.6. The U.S.
        • 9.2.6.1. The U.S. DNA and gene chips market revenue, by type, 2016-2025 (USD Billion)
        • 9.2.6.2. The U.S. DNA and gene chips market revenue, by product, 2016-2025 (USD Billion)
        • 9.2.6.3. The U.S. DNA and gene chips market revenue, by application, 2016-2025 (USD Billion)
        • 9.2.6.4. The U.S. DNA and gene chips market revenue, by end-user, 2016-2025 (USD Billion)
      • 9.2.7. Canada
        • 9.2.7.1. Canada DNA and gene chips market revenue, by type, 2016-2025 (USD Billion)
        • 9.2.7.2. Canada DNA and gene chips market revenue, by product, 2016-2025 (USD Billion)
        • 9.2.7.3. Canada DNA and gene chips market revenue, by application, 2016-2025 (USD Billion)
        • 9.2.7.4. Canada DNA and gene chips market revenue, by end-user, 2016-2025 (USD Billion)
    • 9.3. Europe
      • 9.3.1. Europe DNA and gene chips market, 2016-2025 (USD Billion)
      • 9.3.2. Europe DNA and gene chips market revenue, by type, 2016-2025 (USD Billion)
      • 9.3.3. Europe DNA and gene chips market revenue, by product, 2016-2025 (USD Billion)
      • 9.3.4. Europe DNA and gene chips market revenue, by application, 2016-2025 (USD Billion)
      • 9.3.5. Europe DNA and gene chips market revenue, by end-user, 2016-2025 (USD Billion)
      • 9.3.6. UK
        • 9.3.6.1. UK DNA and gene chips market revenue, by type, 2016-2025 (USD Billion)
        • 9.3.6.2. UK DNA and gene chips market revenue, by product, 2016-2025 (USD Billion)
        • 9.3.6.3. UK DNA and gene chips market revenue, by application, 2016-2025 (USD Billion)
        • 9.3.6.4. UK DNA and gene chips market revenue, by end-user, 2016-2025 (USD Billion)
      • 9.3.7. Germany
        • 9.3.7.1. Germany DNA and gene chips market revenue, by type, 2016-2025 (USD Billion)
        • 9.3.7.2. Germany DNA and gene chips market revenue, by product, 2016-2025 (USD Billion)
        • 9.3.7.3. Germany DNA and gene chips market revenue, by application, 2016-2025 (USD Billion)
        • 9.3.7.4. Germany DNA and gene chips market revenue, by end-user, 2016-2025 (USD Billion)
      • 9.3.8. France
        • 9.3.8.1. France DNA and gene chips market revenue, by type, 2016-2025 (USD Billion)
        • 9.3.8.2. France DNA and gene chips market revenue, by product, 2016-2025 (USD Billion)
        • 9.3.8.3. France DNA and gene chips market revenue, by application, 2016-2025 (USD Billion)
        • 9.3.8.4. France DNA and gene chips market revenue, by end-user, 2016-2025 (USD Billion)
      • 9.3.9. Rest of Europe
        • 9.3.9.1. Rest of Europe DNA and gene chips market revenue, by type, 2016-2025 (USD Billion)
        • 9.3.9.2. Rest of Europe DNA and gene chips market revenue, by product, 2016-2025 (USD Billion)
        • 9.3.9.3. Rest of Europe DNA and gene chips market revenue, by application, 2016-2025 (USD Billion)
        • 9.3.9.4. Rest of Europe DNA and gene chips market revenue, by end-user, 2016-2025 (USD Billion)
    • 9.4. Asia Pacific
      • 9.4.1. Asia Pacific DNA and gene chips market, 2016-2025 (USD Billion)
      • 9.4.2. Asia Pacific DNA and gene chips market revenue, by type, 2016-2025 (USD Billion)
      • 9.4.3. Asia Pacific DNA and gene chips market revenue, by product, 2016-2025 (USD Billion)
      • 9.4.4. Asia Pacific DNA and gene chips market revenue, by application, 2016-2025 (USD Billion)
      • 9.4.5. Asia Pacific DNA and gene chips market revenue, by end-user, 2016-2025 (USD Billion)
      • 9.4.6. China
        • 9.4.6.1. China DNA and gene chips market revenue, by type, 2016-2025 (USD Billion)
        • 9.4.6.2. China DNA and gene chips market revenue, by product, 2016-2025 (USD Billion)
        • 9.4.6.3. China DNA and gene chips market revenue, by application, 2016-2025 (USD Billion)
        • 9.4.6.4. China DNA and gene chips market revenue, by end-user, 2016-2025 (USD Billion)
      • 9.4.7. Japan
        • 9.4.7.1. Japan DNA and gene chips market revenue, by type, 2016-2025 (USD Billion)
        • 9.4.7.2. Japan DNA and gene chips market revenue, by product, 2016-2025 (USD Billion)
        • 9.4.7.3. Japan DNA and gene chips market revenue, by application, 2016-2025 (USD Billion)
        • 9.4.7.4. Japan DNA and gene chips market revenue, by end-user, 2016-2025 (USD Billion)
      • 9.4.8. India
        • 9.4.8.1. India DNA and gene chips market revenue, by type, 2016-2025 (USD Billion)
        • 9.4.8.2. India DNA and gene chips market revenue, by product, 2016-2025 (USD Billion)
        • 9.4.8.3. India DNA and gene chips market revenue, by application, 2016-2025 (USD Billion)
        • 9.4.8.4. India DNA and gene chips market revenue, by end-user, 2016-2025 (USD Billion)
      • 9.4.9. Rest of Asia Pacific
        • 9.4.9.1. Rest of Asia Pacific DNA and gene chips market revenue, by type, 2016-2025 (USD Billion)
        • 9.4.9.2. Rest of Asia Pacific DNA and gene chips market revenue, by product, 2016-2025 (USD Billion)
        • 9.4.9.3. Rest of Asia Pacific DNA and gene chips market revenue, by application, 2016-2025 (USD Billion)
        • 9.4.9.4. Rest of Asia Pacific DNA and gene chips market revenue, by end-user, 2016-2025 (USD Billion)
    • 9.5. Latin America
      • 9.5.1. Latin America DNA and gene chips market, 2016-2025 (USD Billion)
      • 9.5.2. Latin America DNA and gene chips market revenue, by type, 2016-2025 (USD Billion)
      • 9.5.3. Latin America DNA and gene chips market revenue, by product, 2016-2025 (USD Billion)
      • 9.5.4. Latin America DNA and gene chips market revenue, by application, 2016-2025 (USD Billion)
      • 9.5.5. Latin America DNA and gene chips market revenue, by end-user, 2016-2025 (USD Billion)
      • 9.5.6. Brazil
        • 9.5.6.1. Brazil DNA and gene chips market revenue, by type, 2016-2025 (USD Billion)
        • 9.5.6.2. Brazil DNA and gene chips market revenue, by product, 2016-2025 (USD Billion)
        • 9.5.6.3. Brazil DNA and gene chips market revenue, by application, 2016-2025 (USD Billion)
        • 9.5.6.4. Brazil DNA and gene chips market revenue, by end-user, 2016-2025 (USD Billion)
      • 9.5.7. Rest of Latin America
        • 9.5.7.1. Rest of Latin America DNA and gene chips market revenue, by type, 2016-2025 (USD Billion)
        • 9.5.7.2. Rest of Latin America DNA and gene chips market revenue, by product, 2016-2025 (USD Billion)
        • 9.5.7.3. Rest of Latin America DNA and gene chips market revenue, by application, 2016-2025 (USD Billion)
        • 9.5.7.4. Rest of Latin America DNA and gene chips market revenue, by end-user, 2016-2025 (USD Billion)
    • 9.6. The Middle East and Africa
      • 9.6.1. The Middle East and Africa DNA and gene chips market, 2016-2025 (USD Billion)
      • 9.6.2. The Middle East and Africa DNA and gene chips market revenue, by type, 2016-2025 (USD Billion)
      • 9.6.3. The Middle East and Africa DNA and gene chips market revenue, by product, 2016-2025 (USD Billion)
      • 9.6.4. The Middle East and Africa DNA and gene chips market revenue, by application, 2016-2025 (USD Billion)
      • 9.6.5. The Middle East and Africa DNA and gene chips market revenue, by end-user, 2016-2025 (USD Billion)
  •  
  • Chapter 10. Company Profile
    • 10.1. Illumina
      • 10.1.1. Overview
      • 10.1.2. Financials
      • 10.1.3. Product Portfolio
      • 10.1.4. Business Strategy
      • 10.1.5. Recent Developments
    • 10.2. Thermo Fisher Scientific, Inc.
      • 10.2.1. Overview
      • 10.2.2. Financials
      • 10.2.3. Product Portfolio
      • 10.2.4. Business Strategy
      • 10.2.5. Recent Developments
    • 10.3. Macrogen Inc.
      • 10.3.1. Overview
      • 10.3.2. Financials
      • 10.3.3. Product Portfolio
      • 10.3.4. Business Strategy
      • 10.3.5. Recent Developments
    • 10.4. Agilent Technologies
      • 10.4.1. Overview
      • 10.4.2. Financials
      • 10.4.3. Product Portfolio
      • 10.4.4. Business Strategy
      • 10.4.5. Recent Developments
    • 10.5. Greiner Bio One International GmbH
      • 10.5.1. Overview
      • 10.5.2. Financials
      • 10.5.3. Product Portfolio
      • 10.5.4. Business Strategy
      • 10.5.5. Recent Developments
    • 10.6. Perkin Elmer, Inc.
      • 10.6.1. Overview
      • 10.6.2. Financials
      • 10.6.3. Product Portfolio
      • 10.6.4. Business Strategy
      • 10.6.5. Recent Developments
    • 10.7. Asper Biotech
      • 10.7.1. Overview
      • 10.7.2. Financials
      • 10.7.3. Product Portfolio
      • 10.7.4. Business Strategy
      • 10.7.5. Recent Developments
    • 10.8. CapitalBio Corporation
      • 10.8.1. Overview
      • 10.8.2. Financials
      • 10.8.3. Product Portfolio
      • 10.8.4. Business Strategy
      • 10.8.5. Recent Developments
    • 10.9. Oxford Gene Technologies
      • 10.9.1. Overview
      • 10.9.2. Financials
      • 10.9.3. Product Portfolio
      • 10.9.4. Business Strategy
      • 10.9.5. Recent Developments
    • 10.10. Microarrays Inc.
      • 10.10.1. Overview
      • 10.10.2. Financials
      • 10.10.3. Product Portfolio
      • 10.10.4. Business Strategy
      • 10.10.5. Recent Developments
    • 10.11. Arrayit Corporation
      • 10.11.1. Overview
      • 10.11.2. Financials
      • 10.11.3. Product Portfolio
      • 10.11.4. Business Strategy
      • 10.11.5. Recent Developments
    • 10.12. bioMérieux SA
      • 10.12.1. Overview
      • 10.12.2. Financials
      • 10.12.3. Product Portfolio
      • 10.12.4. Business Strategy
      • 10.12.5. Recent Developments

Methodology

Free Analysis

DNA and gene chips are also known as DNA microarrays. DNA microarrays are biochips that are used to detect a large number of genes,  which are present in a gene sample. DNA microarrays are microscopic slides that are made up of thousands of spots present in defined positions. These spots contain particular DNA sequences or DNA genes. This DNA sequence acts as a probe for gene detection and is mainly used to detect large DNA sequences.

According to the World Health Organization, cancer is the second leading cause of deaths worldwide. The growing prevalence of cancer worldwide is fueling the research activities for cancer treatment and diagnosis, which is the major growth driver of the global DNA and gene chips market. The rising number of research activities related to gene expression and drug discovery for the treatment of genetic diseases is also driving the global DNA and gene chips market. Increase in government funding for research activities, growth in the demand for personalized medicines, and an increase in the establishment of pharmaceutical companies in developing countries are other growth drivers of this market. However, the high cost of instruments and the dearth of skilled professionals may hinder the growth of the global DNA and gene chips market.

Global DNA and Gene Chips Market

The market for DNA and gene chips is divided into type, product, application, and end user. By type, the market for DNA and gene chips is bifurcated into oligonucleotide DNA and complementary DNA. Oligonucleotide DNA is anticipated to dominate the market in the future, owing to its high accuracy as compared to complementary DNA. Based on the product, the DNA and gene chips market is fragmented into instruments and consumables. Consumables are predicted to dominate the DNA and gene chips market owing to the constant demand of the consumables because of the growing research activities. Based on application, the DNA and gene chips market includes gene expression, cancer diagnosis and treatment, proteomics, drug discovery, genomics, agricultural biotechnology, and others. Drug discovery is projected to show a higher growth rate in the future, owing to the increase in research activities for drug development to treat chronic and genetic diseases. Based on end-user, the market for DNA and gene chips includes hospital and diagnostic centers, academic and government research institutes, biotechnology and pharmaceutical companies, and others. Biotechnology and pharmaceutical companies are anticipated to show a high growth rate in the years ahead, owing to an increase in the establishment of manufacturing units, particularly in developing countries.

By region, North America dominated the DNA and gene chips market globally in 2018, owing to the early introduction of highly developed research equipment, increase in healthcare spending, the presence of highly skilled workforce, and an increase in the number of R&D projects related to gene expression. The Asia Pacific is anticipated to show the highest year-to-year growth over the forecast time period, owing to the growing investments by government and companies for research activities related to the genome, the rising prevalence of cancer, and rapid technological advancements witnessed in the healthcare sector.

Some key players of the global DNA and gene chips market are Perkin Elmer, Inc., Illumina, Inc., Thermo Fisher Scientific, Inc., Macrogen Inc., Agilent Technologies, Greiner Bio-One International GmbH, Asper Biotech, CapitalBio Corporation, Microarrays Inc., Oxford Gene Technology, Arrayit Corporation, and bioMérieux SA.

}
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com